[DOI] [PMC free article] [PubMed] [Google Scholar] 107.Zhong J., Rao X., Deiuliis J., Braunstein Z., Narula V., Hazey J., Mikami D., Needleman B., Satoskar A.R., Rajagopalan S
Immunoreactive GLP-1 concentrations measured with the GLP-1 sandwich ELISA (EZGLP1T-36K) and the (936)NH 2 specific ELISA increased within the first minute after injection of GLP-1(936)NH 2 , falling quickly thereafter to reach baseline 12 min after injection (ESM Fig
,
When It Might Be Time to Talk to Your Doctor If youve walked through the steps abovechecking your cycle, adjusting your nutrition, and re-engaging your mental toolsbut the food noise still feels as loud as it was before starting medication, it might be time to reach out to your provider
GLP-1: Reduced appetite and food intake, improved blood glucose GIP: Insulin secretion, complementary effects on adipose tissue and metabolism Glucagon: Effects on lipid metabolism and energy expenditure Preclinical and early clinical data suggest that a reduction in energy intake and changes in energy metabolism may contribute to significant weight loss
Heres what the research shows, what to realistically expect, and how triglyceride reduction fits into the broader metabolic picture of GLP-1 therapy
